Dr. Solomon is Professor of Psychology and founding Chairman of the Neuroscience Program at Williams College. He is a licensed Psychologist in Massachusetts and Vermont. He has authored more than 150 books, chapters, and research papers. He is the recipient of a National Research Service Award from the National Institutes of Health. Dr. Solomon is a Fellow of the American Psychological Association and The American Association for the Advancement of Science. He serves on the board of the Massachusetts Chapter of Alzheimer's Association.

Dr. Andrew Budson is Assistant Professor of Neurology at Harvard Medical School and Associate Medical Director of Clinical Trials for Alzheimer's Disease, Brigham & Women's Hospital, Boston. He is a Diplomat of the American Board of Psychiatry and Neurology. He has published numerous research papers in the area of cognitive neuroscience. Dr. Budson is a member of Phi Betta Kappa and is recipient of a National Research Service Award from the National Institutes of Health. He is licensed in Massachusetts and Vermont.

abudson@partners.org
http://www.memorydoc.org/budson

Dr. Lisa K. Catapano-Friedman is a psychiatrist specializing in geriatric, adult, and adolescent psychiatry. Since 1994, Dr. Catapano-Friedman has served as the Chair, Department of Psychiatry, at Southwestern Vermont Medical Center. Dr. Catapano-Friedman, more commonly known as 'Dr. Lisa', graduated from Yale University and Tufts University School of Medicine. From 1982 to 1991, Dr. Lisa was a Clinical Assistant Professor of Psychiatry at UMDNJ-Rutgers. Dr. Lisa is a member of American Psychiatric Association and Vermont Psychiatric Association and a Distinguished Fellow of the American Psychiatric Association. She is Board Certified by the American Board of Psychiatry and Neurology. Dr. Catapano-Friedman is licensed in Massachusetts and Vermont.

Ms. Murphy received her MBA from Columbia University with an emphasis on Pharmaceutical Marketing. Prior to joining the Memory Clinic, she spent 15 years in the pharmaceutical industry at Parke-Davis and Johnson & Johnson (Janssen) working initially in international marketing for Alzheimer's disease and then as the New Product Director for anti-dementia compounds. She is currently a doctoral student in clinical psychology.

Ms. Levin has more than 12 years as a clinical research coordinator. She is highly experienced in all aspects of clinical research in Alzheimer's disease and other neurological disorders. She has coordinated more than 25 clinical trials. Ms. Levin also serves as the regulatory specialist for the clinic.

Ms. Burgher has more than 13 years experience as a laboratory coordinator and has experience in multiple clinical trials.

Ms. Robinson has approximately 5 years of experience administering neuropsychological tests and rating scales. She has participated in multiple clinical trials.